News Releases News Releases Year None201920182016 June 10, 2019 NextCure Reports First Quarter 2019 Financial Results May 13, 2019 NextCure Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares May 8, 2019 NextCure Announces Pricing of Initial Public Offering of Common Stock March 4, 2019 NextCure and Yale Publish Nature Medicine Paper Detailing Novel Immunomedicine Target Siglec-15 February 12, 2019 NextCure Announces Formation of Scientific Advisory Board to Guide Development of its Portfolio of Immunomedicines Tools
News Releases Year None201920182016 June 10, 2019 NextCure Reports First Quarter 2019 Financial Results May 13, 2019 NextCure Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares May 8, 2019 NextCure Announces Pricing of Initial Public Offering of Common Stock March 4, 2019 NextCure and Yale Publish Nature Medicine Paper Detailing Novel Immunomedicine Target Siglec-15 February 12, 2019 NextCure Announces Formation of Scientific Advisory Board to Guide Development of its Portfolio of Immunomedicines
